Corteva Inc. alleges that the development by
Monsanto and Bayer CropScience LP, both units of Bayer’s crop science division, knew of Corteva’s invention and have made and used genetically modified, or transgenic, plants that produce the enzyme, according to a complaint in the US District Court for the District of Delaware.
The patent covers AryloxyAlkanoate Dioxygenase, or AAD-1, proteins and genes, which target both grass weeds ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.